MGC Diagnostics

Saint Pauls, United States Founded: 1977 • Age: 49 yrs Listed Acquired By CAIRE
Non-invasive diagnostic systems for cardiorespiratory health solutions.

About MGC Diagnostics

MGC Diagnostics is a Healthcare company based in Saint Pauls (United States) founded in 1977, and was acquired by CAIRE in December 2022. Non-invasive diagnostic systems for cardiorespiratory health solutions. MGC Diagnostics has completed 1 acquisition, including Lemon Medical. MGC Diagnostics offers products and services including Pulmonary Function Test, Metabolic Test, Indirect Calorimetry, Treadmills, and Ascent Software. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Diversified. Its legal entity is MGC Diagnostics Corporation. Its competitors include SpectraWAVE, Proxim Diagnostics and Boston Heart Diagnostics; 3 of its 3 listed competitors have raised funding.

Company details

MGC Diagnostics Corporation (formerly Angeion Corporation), a medical technology company is focused on cardiorespiratory health solutions. The company develops, manufactures and markets non-invasive diagnostic systems for disease detection, integrated care, and wellness in cardiorespiratory healthcare space.

  • Headquarters Saint Pauls, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mgcdiagnostics.com
  • Social LinkedIn X YouTube
  • Acquired by CAIRE (Dec 2022)
  • Legal Name Mgc Diagnostics Corporation
Key Metrics

Products & Services of MGC Diagnostics

MGC Diagnostics offers a comprehensive portfolio of products and services, including Pulmonary Function Test, Metabolic Test, Indirect Calorimetry, Treadmills, and Ascent Software.

Pulmonary Function Test
Diagnostic Tool

Assesses lung function for respiratory health diagnostics.

Metabolic Test
Diagnostic Tool

Evaluates metabolic rates during exercise and stress testing.

Indirect Calorimetry
Diagnostic Tool

Measures energy expenditure for metabolic analysis.

Treadmills
Exercise Equipment

Supports stress testing in cardiology and sports medicine.

Ascent Software
Software Solution

Manages data for pulmonary and metabolic testing workflows.

Apps and channels of MGC Diagnostics

its YouTube channel MGC Diagnostics has 708 subscribers and 30 videos.

MGC Diagnostics
YouTube 708 subscribers 30 videos Science & Technology
Open channel

Videos from MGC Diagnostics

The most watched videos on MGC Diagnostics's YouTube channel, MGC Diagnostics (708 subscribers). Click a video to play it here.

Intro to Forced Oscillation Technique (FOT) or Oscillometry, using the Resmon PRO FULL V3 System
9.5K views
Performing a Complete Pulmonary Function Test with Ascent Software
8.5K views
Syringe Quality Control with BreezeSuite Software
3.1K views
HAST High Altitude Simulation Testing with MGC Diagnostics
2.8K views

More on MGC Diagnostics.

Funding Insights of MGC Diagnostics

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $18M
  • First Round $18M

    (Jan 2018)

  • Investors Count 1

All 1 funding rounds of MGC Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018$18MDebt – Conventional––
Valuation history

3 investors in total: 3 institutional.

Investors in MGC Diagnostics

MGC Diagnostics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Altus Capital Partners, Caireinc and Abacus Finance.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies.
abacusfinance.comNew York, United States
Private equity firm focused on acquisitions
2003altuscapitalpartners.comWilton, United States
Oxygen generators are manufactured in Pleasanton, United States.
2011caireinc.comPleasanton, United States
Premium access

Investor details for MGC Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MGC Diagnostics

33 people are tracked at MGC Diagnostics (9 in leadership, 24 in team).

NameRoleGroup
Brian Gorter
Director, Software TechnologyLeadership
Ralph Cook Ba
Vice President Of Global Marketing & Product ManagementLeadership
Lisa Knepper Rrt/Rpft
Vice President Of Sales OperationsLeadership
Dinesh Islania
Director Business Development EMEA | India RegionLeadership
Peter Andersson
Sales & Service Director EuropeLeadership
Todd M. Austin
CEOLeadership
Jayson Desrochers
Senior Vice President Of Global Sales & MarketingLeadership
Mike Heino
Vice President Of Global Service And SupportLeadership
Jim McGurran
Senior Vice President - Global R&d, Qa/ra & ITLeadership
Angela Linwood
UI Design / Front End DevelopmentTeam
Scott Nelson
Tech Support Manager/field Service TechnicanTeam
Julie Tracy
Senior Technical Support SpecialistTeam
Mariano Caruso
Representante De VentasTeam
Lee Firminger
National Contract Sales ManagerTeam
Pascal Maire
Business Developper Rehab FranceTeam
Lindsey Lentz
Software Implementation SpecialistTeam
Rein Ripperger
Sr. Technical Support Specialist & Field Service EngineerTeam
Mark Yenney
RetiredTeam
Corina Lentz-Reyes
Quality Systems Manager / Regulatory AffairsTeam
David Mason
Mechanical EngineerTeam

13 more people are available in the full profile.

Premium access

Complete people profiles for MGC Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MGC Diagnostics

MGC Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lemon Medical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diagnostic testing products are developed for medical applications in Germany.
lemonmed.comHammelburg, Germany2009Nov 2021β€’β€’β€’β€’
Premium access

Complete acquisition details for MGC Diagnostics

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MGC Diagnostics

6 dated milestones of MGC Diagnostics across 45 years, from founding to its latest funding, stage changes and deals.

  1. Founded MGC Diagnostics is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Exit Acquired by Altus Capital Partners.
  4. Funding First funding round of $18.0M.
  5. Acquisition Acquires Lemon Medical.
  6. Exit Acquired by CAIRE.

Competitors of MGC Diagnostics

MGC Diagnostics has 3 listed competitors in our database, 3 of them funded. They include SpectraWAVE, Proxim Diagnostics and Boston Heart Diagnostics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
spectrawave.com2012Waltham, United States$79.88M36
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
proximdx.com2010Sunnyvale, United States$22.9M
Handheld immunodiagnostic devices for cardiac vascular diseases are developed.
bostonheartdiagnostics.com2007Framingham, United States$10.34M
Diagnostics for personalized cardiovascular disease management are developed.
Premium access

Detailed competitors of MGC Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MGC Diagnostics

The website of MGC Diagnostics (mgcdiagnostics.com) receives about 9.5K visits a month.

  • Monthly visits
    9.5K

    ▼ 16.2% vs previous month

Similar websites

Websites whose visitors overlap most with MGC Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nddmed.com
100%
47.3K#699,243View details
huma.com
86%
39K#844,664View details
rtmagazine.com
rtmagazine.com
79%
–
dremed.com
79%
10.4K#2,284,484View details
medical-dictionary.thefreedictionary.com
medical-dictionary.thefreedictionary.com
79%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 14 similar websites and full traffic analytics for MGC Diagnostics

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 14 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as MGC Diagnostics (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mgc Diagnostics

Premium access

Complete news archive for MGC Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MGC Diagnostics

MGC Diagnostics was founded in 1977 and raised its 1st funding round 41 years after it was founded.

MGC Diagnostics is headquartered in Saint Pauls, United States. It is registered at Saint Pauls, North Carolina, United States.

MGC Diagnostics Corporation (formerly Angeion Corporation), a medical technology company is focused on cardiorespiratory health solutions. The company develops, manufactures and markets non-invasive diagnostic systems for disease detection, integrated care, and wellness in cardiorespiratory healthcare space.

MGC Diagnostics's top competitors include SpectraWAVE, Boston Heart Diagnostics and Proxim Diagnostics.

MGC Diagnostics offers Pulmonary Function Test, Metabolic Test, Indirect Calorimetry, Treadmills, and Ascent Software.

MGC Diagnostics has made 1 acquisition, including Lemon Medical.

MGC Diagnostics has 3 investors. Key investors include Altus Capital Partners, Caireinc, and Abacus Finance.

MGC Diagnostics operates through Mgc Diagnostics Corporation.

Yes. MGC Diagnostics was acquired by CAIRE in December 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available